Literature DB >> 19255786

Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.

Rashad Abdul-Ghani1, Naguiba Loutfy, Amel el-Sahn, Azza Hassan.   

Abstract

Schistosomiasis still represents a major health problem in many tropical and subtropical countries despite continuing control efforts. Due to the unavailability of a vaccine that is practically applicable to humans, the use of chemotherapy is the mainstay of schistosomiasis-associated morbidity control. This paper attempts to review the antischistosomal drugs currently used in the treatment of intestinal schistosomiasis caused by Schistosoma mansoni. Their antischistosomal properties, advantages, and disadvantages as well as issues regarding the evidence for drug resistance and combination studies are reviewed in a simple manner. The recent trends towards the identification of specific chemotherapeutic targets for the treatment of schistosomes are also discussed briefly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255786     DOI: 10.1007/s00436-009-1371-7

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  102 in total

1.  Therapeutic effect of praziquantel enantiomers in mice infected with Schistosoma mansoni.

Authors:  S Xiao; J Chollet; M Booth; N A Weiss; M Tanner
Journal:  Trans R Soc Trop Med Hyg       Date:  1999 May-Jun       Impact factor: 2.184

2.  Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni.

Authors:  S H Xiao; B A Catto
Journal:  J Infect Dis       Date:  1989-03       Impact factor: 5.226

Review 3.  Antischistosomal drugs: past, present ... and future?

Authors:  D Cioli; L Pica-Mattoccia; S Archer
Journal:  Pharmacol Ther       Date:  1995       Impact factor: 12.310

4.  In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study.

Authors:  H Mehlhorn; B Becker; P Andrews; H Thomas; J K Frenkel
Journal:  Arzneimittelforschung       Date:  1981

5.  Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.

Authors:  J Utzinger; J Chollet; J You; J Mei; M Tanner; S Xiao
Journal:  Acta Trop       Date:  2001-09-01       Impact factor: 3.112

6.  Experimental trials of an artemisinin derivative in treatment of Schistosoma mansoni infected mice.

Authors:  S S Abdel Aziz; N M el-Badawy
Journal:  J Egypt Soc Parasitol       Date:  2000-04

7.  Artemether administered together with haemin damages schistosomes in vitro.

Authors:  S Xiao; J Chollet; J Utzinger; H Matile; J Mei; M Tanner
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.184

8.  In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni.

Authors:  S H Xiao; B A Catto
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

9.  Identification of an antimalarial synthetic trioxolane drug development candidate.

Authors:  Jonathan L Vennerstrom; Sarah Arbe-Barnes; Reto Brun; Susan A Charman; Francis C K Chiu; Jacques Chollet; Yuxiang Dong; Arnulf Dorn; Daniel Hunziker; Hugues Matile; Kylie McIntosh; Maniyan Padmanilayam; Josefina Santo Tomas; Christian Scheurer; Bernard Scorneaux; Yuanqing Tang; Heinrich Urwyler; Sergio Wittlin; William N Charman
Journal:  Nature       Date:  2004-08-19       Impact factor: 49.962

Review 10.  Qinghaosu (artemisinin): an antimalarial drug from China.

Authors:  D L Klayman
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

View more
  22 in total

1.  In vitro efficacy of the essential oil of Piper cubeba L. (Piperaceae) against Schistosoma mansoni.

Authors:  Lizandra G Magalhães; Julia M de Souza; Kamila A L Wakabayashi; Rosangela da S Laurentiz; Adriana H C Vinhólis; Karen C S Rezende; Guilherme V Simaro; Jairo K Bastos; Vanderlei Rodrigues; Viviane R Esperandim; Daniele S Ferreira; Antônio E M Crotti; Wilson R Cunha; Márcio L A e Silva
Journal:  Parasitol Res       Date:  2011-10-19       Impact factor: 2.289

2.  Morphological and morphometric study of cercariae and adult worms of Schistosoma mansoni (SLM strain) isolated from infected mice.

Authors:  A S A Pereira; N L Cavalcanti; G A F Nascimento; J L G Nascimento-Silva; R J R Padilha; L F W Viegas; L C Alves; J L Lima-Filho; M E C Chaves
Journal:  Parasitol Res       Date:  2012-12-20       Impact factor: 2.289

3.  Physicochemical properties and anti-opisthorchosis effect of mechanochemically synthesized supramolecular complexes of Albendazole with the polysaccharide Arabinogalactan from Larix sibirica and Larix gmelinii.

Authors:  Yu S Chistyachenko; M V Khvostov; A I Belousov; N A Zhukova; M Yu Pakharukova; A V Katokhin; S S Khalikov; T G Tolstikova; A V Dushkin; V A Mordvinov; N Z Lyakhov
Journal:  Dokl Biol Sci       Date:  2014-07-02

4.  Effect of Mirazid in Schistosoma japonicum-infected mice: parasitological and pathological assessment.

Authors:  Mohamed A El-Malky; Shao-Hong Lu; Samar N El-Beshbishi; Niveen S Saudy; Nobu Ohta
Journal:  Parasitol Res       Date:  2012-10-03       Impact factor: 2.289

5.  Effectiveness of synthetic trioxolane OZ78 against Schistosoma japonicum in mice and rabbits.

Authors:  Shu-Hua Xiao; Jian Xue; Jing-Yan Mei; Pei-Ying Jiao
Journal:  Parasitol Res       Date:  2011-12-27       Impact factor: 2.289

6.  Artemether shows promising female schistosomicidal and ovicidal effects on the Egyptian strain of Schistosoma mansoni after maturity of infection.

Authors:  Rashad Abdul-Ghani; Naguiba Loutfy; Manal Sheta; Azza Hassan
Journal:  Parasitol Res       Date:  2010-11-25       Impact factor: 2.289

7.  A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility.

Authors:  Michael J Smout; Andrew C Kotze; James S McCarthy; Alex Loukas
Journal:  PLoS Negl Trop Dis       Date:  2010-11-16

8.  Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasis.

Authors:  C Lochmatter; C L Schneider; K Ingram; J Keiser; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

Review 9.  Present-day anthelmintics and perspectives on future new targets.

Authors:  Amira Taman; Manar Azab
Journal:  Parasitol Res       Date:  2014-06-04       Impact factor: 2.289

10.  Efficacy and safety of arachidonic acid for treatment of Schistosoma mansoni-infected children in Menoufiya, Egypt.

Authors:  Sahar Selim; Ola El Sagheer; Azza El Amir; Rashida Barakat; Kevin Hadley; Maaike J Bruins; Rashika El Ridi
Journal:  Am J Trop Med Hyg       Date:  2014-09-22       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.